New math model controls biological noise at single-cell level, offering a path to tackle cancer relapse and drug resistance.
A new, high-performance brain-computer interface (BCI) can be rapidly implanted through a minimally invasive procedure. The ...
Abstract: Complicated deformation problems are frequently encountered in medical image registration tasks. Although various advanced registration models have been proposed, accurate and efficient ...
Abstract: Dear Editor, This letter deals with the distributed recursive set-membership filtering (DRSMF) issue for state-saturated systems under encryption-decryption mechanism. To guarantee the data ...
Correspondence to Dr Andreas Höhn, MRC/CSO Social and Public Health Sciences Unit, University of Glasgow, Glasgow, G12 8TB, UK; andreas.hoehn{at}glasgow.ac.uk Background Many complex public health ...
Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...
In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback